Want to see SE:STIL full AI Analyst Report?
Top Page
Stille AB
(STIL)
Select Model
Select Model
Rating:69Neutral
Price Target:
kr247.00
▲(32.44% Upside)
Action:Downgraded
Date:07/24/26
The score is driven primarily by strong financial performance, especially the debt-free balance sheet and solid profitability. Offsetting this are a relatively expensive valuation (high P/E) and only neutral-to-mild technical momentum (slightly negative MACD with otherwise neutral indicators).
Positive Factors
Debt-free balance sheet
A debt-free structure and large equity base materially reduce financial risk, interest burden and refinancing needs. This gives Stille resilience to operating volatility and preserves flexibility to fund product development, capacity or acquisitions over the next several months.
Negative Factors
Uneven free cash flow
Recent free-cash-flow improvement is encouraging, but the sharp prior decline shows that cash conversion is less consistent than earnings. Persistent variability could constrain internally funded investment and make results more sensitive to working-capital or operating changes.
Read all positive and negative factors
Positive Factors
Negative Factors
Debt-free balance sheet
A debt-free structure and large equity base materially reduce financial risk, interest burden and refinancing needs. This gives Stille resilience to operating volatility and preserves flexibility to fund product development, capacity or acquisitions over the next several months.
Read all positive factors
Stille AB (STIL) vs. iShares MSCI Sweden ETF (EWD)
Market Cap
kr2.05B
Dividend Yield1.62%
Average Volume (3M)6.33K
Price to Earnings (P/E)28.3
Beta (1Y)0.25
Revenue Growth25.46%
EPS Growth39.03%
CountrySE
Employees225
SectorGeneral
Sector StrengthN/A
IndustryMedical - Instruments & Supplies
Share Statistics
EPS (TTM)8.09
Shares Outstanding8,985,447
10 Day Avg. Volume8,939
30 Day Avg. Volume6,328
Financial Highlights & Ratios
PEG Ratio-7.85
Price to Book (P/B)2.48
Price to Sales (P/S)3.10
P/FCF Ratio113.92
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)8.97
Revenue Forecast (FY)kr723.50M
Stille AB Business Overview & Revenue Model
Company Description
Stille AB develops, manufactures, and distributes medtech products in Sweden and internationally. It operates through the Surgical Instruments and Surgical Tables segments. The Surgical Instruments segment offers surgical scissors, including Super...
How the Company Makes Money
Stille makes money primarily by selling medical-technology products to hospitals and healthcare providers. Its core revenue streams are (1) sales of precision surgical instruments (e.g., reusable instruments used in demanding surgical procedures) ...
Stille AB Financial Statement Overview
Summary
Income Statement
78
Positive
Balance Sheet
90
Very Positive
Cash Flow
67
Positive
| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 679.58M | 567.63M | 569.95M | 294.89M | 246.35M | 187.09M |
| Gross Profit | 335.42M | 287.97M | 295.64M | 132.17M | 111.57M | 83.46M |
| EBITDA | 126.02M | 109.01M | 118.97M | 56.04M | 44.78M | 28.89M |
| Net Income | 72.59M | 55.70M | 58.21M | 26.65M | 27.32M | 16.10M |
Balance Sheet | ||||||
| Total Assets | 1.13B | 1.05B | 1.00B | 804.89M | 342.55M | 308.85M |
| Cash, Cash Equivalents and Short-Term Investments | 149.36M | 118.66M | 158.49M | 241.45M | 36.68M | 27.80M |
| Total Debt | 0.00 | 123.26M | 63.09M | 62.94M | 70.77M | 81.48M |
| Total Liabilities | 359.37M | 345.54M | 301.70M | 172.64M | 152.74M | 160.75M |
| Stockholders Equity | 774.29M | 708.71M | 699.40M | 632.25M | 189.81M | 148.10M |
Cash Flow | ||||||
| Free Cash Flow | 40.08M | 15.46M | 59.24M | 24.37M | 23.89M | -11.74M |
| Operating Cash Flow | 64.07M | 36.05M | 73.53M | 37.28M | 31.94M | 7.28M |
| Investing Cash Flow | -114.72M | -104.30M | -330.31M | -12.90M | -8.04M | -51.90M |
| Financing Cash Flow | 40.84M | 36.16M | 171.40M | 178.99M | -18.54M | 33.22M |
Stille AB Technical Analysis
Neutral
186.50
Price Trends
240.82
Negative
244.03
Negative
215.88
Positive
Market Momentum
-4.02
Negative
46.01
Neutral
61.43
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For SE:STIL, the sentiment is Neutral. The current price of 186.5 is below the 20-day moving average (MA) of 229.90, below the 50-day MA of 240.82, and below the 200-day MA of 215.88, indicating a neutral trend. The MACD of -4.02 indicates Negative momentum. The RSI at 46.01 is Neutral, neither overbought nor oversold. The STOCH value of 61.43 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for SE:STIL.
Stille AB Peers Comparison
UnderperformOutperform
Sector (55)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
73 Outperform | kr2.56B | 27.76 | ― | ― | 8.40% | 0.74% | |
72 Outperform | kr14.95B | 68.77 | 23.82% | ― | 21.08% | 44.49% | |
72 Outperform | kr19.67B | 32.36 | 10.82% | 0.95% | 0.82% | 77.45% | |
69 Neutral | kr2.05B | 28.26 | ― | 1.62% | 25.46% | 39.03% | |
55 Neutral | $6.65B | 3.83 | -15.92% | 6.20% | 10.91% | 7.18% | |
42 Neutral | kr404.34M | -8.13 | ― | ― | -2.61% | -0.28% | |
41 Neutral | kr583.67M | -7.98 | ― | ― | ― | -23.57% |
* General Sector Average
SE:STIL
Stille AB
228.50
-1.50
-0.65%
SE:ALIF.B
AddLife AB
157.90
-22.33
-12.39%
SE:BONEX
BONESUPPORT HOLDING AB
222.80
-89.60
-28.68%
SE:SUS
Surgical Science Sweden AB
50.80
-41.95
-45.23%
SE:OSSD
OssDsign AB
3.68
-12.02
-76.56%
SE:FLUO
FluoGuide A/S
35.70
-4.50
-11.19%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.